News Daily News Cancelled Cath Lab Activations and Timely Reperfusion: A ‘Balancing Act’ Michael O'Riordan August 21, 2018
News Daily News BMI, Blood Pressure Strongly Linked Across Diverse Subgroups in China Caitlin E. Cox August 21, 2018
News Daily News Hospital Readmissions at 30 Days Declining for Stroke Patients Michael O'Riordan August 20, 2018
News Daily News ADAPT-DES: High On-Aspirin Platelet Reactivity Not Related to PCI Outcomes Todd Neale August 17, 2018
News Opinion Fellow Talk Three Lessons Learned in Using Myocardial Viability to Guide Multivessel Revascularization Yashasvi Chugh, MD August 16, 2018
News Daily News Edoxaban Looks Good for Asians With A-fib in Real-world Analysis Todd Neale August 14, 2018
News Daily News Intracranial Hemorrhage Outside of A-fib: Different NOACs, Different Risks Todd Neale August 13, 2018
News Daily News Ischemic Stroke Risk Scoring May Not Be Accurate for Patients With Atrial Flutter L.A. McKeown August 03, 2018
News Daily News New Consensus Statement: NOAC and Clopidogrel for Most A-fib Patients Treated With PCI Michael O'Riordan July 31, 2018
News Daily News Experts Give Strong Support for PFO Closure in New ‘Rapid Recommendations’ Todd Neale July 26, 2018
News Daily News Asian Patients With A-fib Don’t Gain Anything From Low-Dose Rivaroxaban Todd Neale July 24, 2018
News Daily News Chew on This: Review Tackles Controversies in Nutrition for CV Health Lucy Hicks July 23, 2018
News Conference News SCCT 2018 Where Progress Meets Payment: Cardiac CT Advocates Debate the Need for an NCD Yael L. Maxwell July 19, 2018
News Daily News NOACs Particularly Beneficial for Women With A-fib, Study Suggests Todd Neale July 11, 2018
News Daily News IV Alteplase No Help for Minor, Nondisabling Strokes in PRISMS Trial Todd Neale July 11, 2018
News Daily News Bleeding Risk Increased With NSAID Use in Anticoagulated A-fib Patients: RE-LY Analysis L.A. McKeown July 10, 2018
News Daily News Real-world Analysis Suggests Apixaban Is Safest of the NOACs, Even for Patients With A-fib L.A. McKeown July 06, 2018
News Daily News Rivaroxaban Offers Net Reduction in Fatal or Irreversible Events in ACS: ATLAS ACS-2 TIMI-51 Michael O'Riordan July 06, 2018